| 1 | [SID49823402] | Active | Potency | 2.8184 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 2 | [SID49823402] | Active | Potency | 3.9811 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 3 | [SID49823402] | Active | AbsAC1000_uM | 5.146 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | AbsAC1000_uM | 5.146 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 4 | [SID49823402] | Active | Potency | 10.4179 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | Potency | 10.4179 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID49823402] | Active | AbsAC35_uM | 11.32 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity [AID652041, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | AbsAC35_uM | 11.32 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (HB3 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-06_Inhibitor_Dose_CherryPick_Activity | | AID | 652041 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID49823402] | Active | AbsAC35_uM | 11.84 | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity [AID652047, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | AbsAC35_uM | 11.84 [uM] | | BioAssay | Cell-based secondary assay to test the inhibitory activity of small molecule on Plasmodium flaciparum (3D7 strain) survival in red blood cells Measured in Cell-Based System Using Plate Reader - 2120-05_Inhibitor_Dose_CherryPick_Activity | | AID | 652047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID49823402] | Active | Potency | 15.8489 | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression [AID624263, Type: confirmatory] | Parkin [Homo sapiens] [gi:3063388] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression | | AID | 624263 | | BioAssay type | confirmatory | | Target | Parkin [Homo sapiens] [gi:3063388] | | PubMed | | | Data Table |  |
|
| 8 | [SID49823402] | Active | | | uHTS fluorescent assay for identification of inhibitors of ATG4B [AID504462, Type: screening] | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | uHTS fluorescent assay for identification of inhibitors of ATG4B | | AID | 504462 | | BioAssay type | screening | | Target | cysteine protease ATG4B isoform a [Homo sapiens] [gi:47132611] | | PubMed | | | Data Table |  |
|
| 9 | [SID49823402] | Active | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 10 | [SID49823402] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 11 | [SID49823402] | Active | | | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay [AID588402, Type: other] | phospholipase A2 precursor [Homo sapiens] [gi:4505847] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Single concentration counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | | AID | 588402 | | BioAssay type | other | | Target | phospholipase A2 precursor [Homo sapiens] [gi:4505847] | | PubMed | | | Data Table |  |
|
| 12 | [SID49823402] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 13 | [SID49823402] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 14 | [SID49823402] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) [AID492953, Type: screening] | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2) | | AID | 492953 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit beta isoform b [Homo sapiens] [gi:296080766] | | PubMed | | | Data Table |  |
|
| 15 | [SID49823402] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 16 | [SID49823402] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 17 | [SID49823402] | Active | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID49823402] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay [AID624504, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay | | AID | 624504 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID49823402] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 20 | [SID49823402] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 21 | [SID49823402] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 22 | [SID49823402] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID49823402] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels [AID2239, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels | | AID | 2239 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 24 | [SID49823402] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels [AID2239, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels | | AID | 2239 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 25 | [SID49823402] | Active | | | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels [AID2287, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels | | AID | 2287 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 26 | [SID49823402] | Active | | | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels [AID2287, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels | | AID | 2287 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 27 | [SID49823402] | Active | | | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase [AID2805, Type: screening] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase | | AID | 2805 | | BioAssay type | screening | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 28 | [SID49823402] | Active | | | Counter screen for compounds that potentiate KCNQ2 potassium channels [AID2282, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Counter screen for compounds that potentiate KCNQ2 potassium channels | | AID | 2282 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 29 | [SID49823402] | Active | | | Counter screen for compounds that potentiate KCNQ2 potassium channels [AID2282, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Active | | BioAssay | Counter screen for compounds that potentiate KCNQ2 potassium channels | | AID | 2282 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 30 | [SID49823402] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 31 | [SID49823402] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 32 | [SID49823402] | Inactive | Potency | 6.3096 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | 6.3096 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 33 | [SID49823402] | Inactive | Potency | 8.9125 | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 34 | [SID49823402] | Inactive | Potency | 10 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49823402] | Inactive | Potency | 28.1838 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 36 | [SID49823402] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 37 | [SID49823402] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 38 | [SID49823402] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 39 | [SID49823402] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 40 | [SID49823402] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 41 | [SID49823402] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 42 | [SID49823402] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 43 | [SID49823402] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 44 | [SID49823402] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 45 | [SID49823402] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 46 | [SID49823402] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 47 | [SID49823402] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 48 | [SID49823402] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 49 | [SID49823402] | Inactive | | | Counter screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID2105, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Counter screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 2105 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 50 | [SID49823402] | Inactive | | | Specificity screen against Kir2.1 for compounds that potentiate KCNQ2 [AID2345, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49823402 | | CID | 20179591 | | Outcome | Inactive | | BioAssay | Specificity screen against Kir2.1 for compounds that potentiate KCNQ2 | | AID | 2345 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|